Literature DB >> 31807547

Performance of modified carbapenem inactivation method and inhibitor-based combined disk test in the detection and distinguishing of carbapenemase producing Enterobacteriaceae.

Juan Li1, Congrong Li1, Xuan Cai1, Jinling Shi1, Lina Feng1, Kewen Tang1, Yongqing Tong1, Yan Li1.   

Abstract

BACKGROUND: This study aimed to evaluate the performance of modified carbapenem inactivation method (mCIM) combined EDTA-carbapenem inactivation method (eCIM), and inhibitor-based combined disk test (CDT) in the detection and distinguishing of carbapenemase production in Enterobacteriaceae.
METHODS: A total of 101 nonrepetitive carbapenem insensitive Enterobacteriaceae [minimal inhibitory concentration (MIC) ≥2 µg/mL] were tested by mCIM, eCIM and CDT respectively, and the major carbapenemase genes including blaKPC, blaNDM, blaIMP, blaVIM and blaOXA-48-like genes were detected by polymerase chain reaction (PCR) as control.
RESULTS: Seventy-nine (78.2%) of isolates were found to harbour one or more carbapenemase genes by PCR, with blaKPC and blaNDM being the most common genes. OXA-48-like genes were undetectable. The coincidence rate of mCIM combined eCIM and CDT was 97.5% (77/79) and 96.2% (76/79) respectively, compared with gene detection. Both assays had a misclassification in two blaKPC+NDM-producing isolates of Klebsiella oxytoca. The sensitivity and specificity of two assays above were 100.0% vs. 95.0% and 98.4% vs. 98.4%, respectively in distinguishing serine-carbapenemase, while they were 95.1% vs. 97.6% and 100% vs. 100.0%, respectively in distinguishing metallo-carbapenemase.
CONCLUSIONS: mCIM combined eCIM and the CDT are both useful tools for the reliable detection and distinguishing single serine-carbapenemase or metallo-carbapenemase, but not for mixed types. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  EDTA-carbapenem inactivation method (eCIM); Modified carbapenem inactivation method (mCIM); carbapenemase-producing Enterobacteriaceae (CPE); combined disk test (CDT)

Year:  2019        PMID: 31807547      PMCID: PMC6861796          DOI: 10.21037/atm.2019.09.43

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  23 in total

Review 1.  Carbapenems in clinical practice: a guide to their use in serious infection.

Authors:  J S Bradley; J Garau; H Lode; K V Rolston; S E Wilson; J P Quinn
Journal:  Int J Antimicrob Agents       Date:  1999-02       Impact factor: 5.283

2.  Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.

Authors:  Ze-Qing Wei; Xiao-Xing Du; Yun-Song Yu; Ping Shen; Ya-Gang Chen; Lan-Juan Li
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.

Authors:  François Caméléna; Aurélie Cointe; Vincent Mathy; Claire Hobson; Catherine Doit; Béatrice Bercot; Dominique Decré; Isabelle Podglajen; Laurent Dortet; Audrey Monjault; Philippe Bidet; Stéphane Bonacorsi; André Birgy
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

4.  An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae.

Authors:  Elizabeth B Hirsch; Kai-Tai Chang; Paola C Zucchi; Dennis N Francoeur; Kimberly R Ledesma; Vincent H Tam; Todd M Lasco
Journal:  J Infect Chemother       Date:  2013-12-11       Impact factor: 2.211

5.  Comparative Evaluation of Four Phenotypic Methods for Detection of Class A and B Carbapenemase-Producing Enterobacteriaceae in China.

Authors:  Menglan Zhou; Danchen Wang; Timothy Kudinha; Qiwen Yang; Shuying Yu; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

6.  Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015-16.

Authors:  David M Livermore; Danièle Meunier; Katie L Hopkins; Michel Doumith; Robert Hill; Rachel Pike; Peter Staves; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2018-03-01       Impact factor: 5.790

7.  Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Authors:  Pranita D Tamma; Katherine E Goodman; Anthony D Harris; Tsigereda Tekle; Ava Roberts; Abimbola Taiwo; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2016-11-09       Impact factor: 9.079

8.  Association of Novel Nonsynonymous Single Nucleotide Polymorphisms in ampD with Cephalosporin Resistance and Phylogenetic Variations in ampC, ampR, ompF, and ompC in Enterobacter cloacae Isolates That Are Highly Resistant to Carbapenems.

Authors:  Baharak Babouee Flury; Matthew J Ellington; Katie L Hopkins; Jane F Turton; Michel Doumith; Richard Loy; Peter Staves; Vladimira Hinic; Reno Frei; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

9.  Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.

Authors:  Anton Y Peleg; Clare Franklin; Jan M Bell; Denis W Spelman
Journal:  Clin Infect Dis       Date:  2005-10-31       Impact factor: 9.079

10.  Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae.

Authors:  Fernando Pasteran; Tania Mendez; Leonor Guerriero; Melina Rapoport; Alejandra Corso
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

View more
  2 in total

1.  Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt.

Authors:  Samar S Mabrouk; Ghada R Abdellatif; Mona R El-Ansary; Khaled M Aboshanab; Yasser M Ragab
Journal:  Infect Drug Resist       Date:  2020-09-11       Impact factor: 4.003

2.  Multiplex lateral flow immunochromatographic assay is an effective method to detect carbapenemases without risk of OXA-48-like cross reactivity.

Authors:  Hadas Kon; Shirin Abramov; Sammy Frenk; David Schwartz; Ohad Shalom; Amos Adler; Yehuda Carmeli; Jonathan Lellouche
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-09-04       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.